# A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation

> **NCT07820930** · NA · NOT_YET_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 650 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Persistent Atrial Fibrillation (PersAF)
- Paroxysmal Atrial Fibrillation (PAF)

## Interventions

- **DEVICE:** FARAFLEX Mapping and Pulsed Field Ablation System

## Key facts

- **NCT ID:** NCT07820930
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11
- **Primary completion:** 2029-07
- **Final completion:** 2031-07
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07820930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07820930, "A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07820930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
